A Discussion about Modalities of Smoking Cessation in Perioperative Phase for Addicts: A Review Article
Journal Title: Journal of Addiction Medicine and Therapeutic Science - Year 2015, Vol 1, Issue 1
Abstract
Cigarette smoking is a worldwide healthcare problem of modern age. It is a leading cause of death, mainly in male population. Excess deaths among smokers, as compared to non smokers, are chiefly due to tuberculosis and respiratory, cardiovascular or malignant diseases. Smoking significantly increases intraoperative and postoperative complications in a person undergoing surgical procedure. Smoking is menace to people and physicians and cessation of smoking is very much desirable, especially in persons undergoing operative intervention. Smoking cessation prior to the operation has been traditionally advised to be for 6 weeks but such an endeavour may have unwanted consequences because of withdrawal symptoms. Hence it is necessary that smoking cessation is achieved with minimal consequences so that the operative procedure can be conducted with minimal problems. Smoking cessation for a current user needs an active approach and provision of support for a cessation attempt. A combination of pharmacotherapy with behavioral interventions provides the best results. Available treatment modalities are nicotine replacement therapy and non-nicotine therapies such as bupropion, nortriptyline and varenicline. The most commonly used drugs are varenicline and bupropion. The focus of this article is on partial selective nicotine receptor agonist drug varenicline. By comparing different studies and researches worldwide, we showed in this article that varenicline provides the most sustaining and cost effective result. It also has less cardiovascular and respiratory side effects than nicotine replacement therapy and bupropion. The only limiting side effect may be psychiatric side effects including depression, self harm and suicidal tendencies, though they warrant further investigation and research.
Authors and Affiliations
Adhikari Dhiman, Sandeep KK, Rajat C, Anupam G, Dasgupta CS
Keywords
Related Articles
- EP ID EP322355
- DOI 10.17352/2455-3484.000002
- Views 110
- Downloads 0
The Effects of Beverage Specific Alcohol Sale on Liver Cirrhosis Mortality in Russia
Background: Liver cirrhosis is a major cause of deaths in many developed countries. There is evidence that beverage preference may have modifying influence on liver cirrhosis risk independently of the amount of alcohol c...
Alcohol and Suicide in Eastern Europe
Suicide is one of the leading external causes of death in many countries and it burden is expected to be rising [1]. There are a number of possible reasons responsible for this including lessened social integration, incr...
PTSD and Intimate Partner Violence: Clinical Considerations and Treatment Options
Intimate partner violence (IPV) is a serious public health concern affecting over 40 million individuals at least once during their lifetime. Among the various negative implications for partners and families are economic...
Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
Background: Since its U.S. FDA approval in 2002, buprenorphine has been available for maintenance treatment of opiate dependence in primary care physicians’ offices. Though buprenorphine was intended to facilitate access...
Risks of Methadone use as Substitute Therapy for Opioid Addiction during Pregnancy and use of Clonidine as a Plausible Alternative
Detoxification of opioid addiction during the pregnancy has been avoided since 1970 after some reports showed untoward outcome including stillbirth and acute narcotic withdrawal syndrome in neonates. It was recommended a...